NCT04686799View on ClinicalTrials.gov

Doxycycline for Elbow Tendinopathy

PHASE1Active, not recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 3, 2020

Primary Completion Date

November 30, 2025

Study Completion Date

November 30, 2025

Conditions

Lateral EpicondylitisLateral Epicondylitis, Left ElbowLateral Epicondylitis, Right ElbowLateral Epicondylitis, Unspecified ElbowLateral Epicondylitis (Tennis Elbow) BilateralMedial EpicondylitisMedial Epicondylitis, Right ElbowMedial Epicondylitis, Left Elbow

Interventions

DRUG

Doxycycline Hyclate 20 MG

Subjects will receive doxycycline 20 mg BID

Trial Locations (1)

10021

Hospital for Special Surgery, New York

All Listed Sponsors

lead

Hospital for Special Surgery, New York

OTHER

NCT04686799 - Doxycycline for Elbow Tendinopathy | Biotech Hunter | Biotech Hunter